Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) EPS (Basic) (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of EPS (Basic) data on record, last reported at $1.0 in Q3 2025.

  • For Q3 2025, EPS (Basic) rose 244.83% year-over-year to $1.0; the TTM value through Sep 2025 reached $1.85, down 32.48%, while the annual FY2024 figure was $0.39, 72.73% down from the prior year.
  • EPS (Basic) reached $1.0 in Q3 2025 per COLL's latest filing, up from $0.38 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.06 in Q2 2021 and bottomed at -$0.73 in Q4 2021.
  • Average EPS (Basic) over 5 years is $0.33, with a median of $0.38 recorded in 2023.
  • Peak YoY movement for EPS (Basic): tumbled 465.0% in 2021, then surged 6000.0% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.73 in 2021, then surged by 71.23% to -$0.21 in 2022, then surged by 571.43% to $0.99 in 2023, then tumbled by 60.61% to $0.39 in 2024, then surged by 156.41% to $1.0 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $1.0 in Q3 2025, $0.38 in Q2 2025, and $0.08 in Q1 2025.